Jyong Biotech Ltd.MENS
Price (close)
$2.15
Market cap
$157.7M
P/E
—
Revenue (FY)
—
Net income
-$4.7M
Dividend yield
—
1-year total return
-96.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Jyong Biotech Ltd. does.
drugs to meet our customers’ health needs. We seek to be a valuable business organization that is held in high esteem by the public.
in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing
that encompass all key functionalities of drug development, including early-stage drug discovery and development, clinical trials, regulatory
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net income | — | -$4.4M | -$3.0M | -$4.7M |
More on MENS.
- Jyong Biotech Ltd. summary
- Jyong Biotech Ltd. financial statements
- Jyong Biotech Ltd. key metrics
- Jyong Biotech Ltd. health scores and style box
- Jyong Biotech Ltd. earnings
- Jyong Biotech Ltd. dividends
- Jyong Biotech Ltd. valuation
- Jyong Biotech Ltd. ownership and insiders
- Jyong Biotech Ltd. peers
Figures from Jyong Biotech Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.